HeartBeam, Inc.
General ticker "BEAT" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $50.4M (TTM average)
HeartBeam, Inc. follows the US Stock Market performance with the rate: 1.5%.
Estimated limits based on current volatility of 2.2%: low 0.87$, high 0.90$
Factors to consider:
- Total employees count: 21 (+40.0%) as of 2024
- Top business risk factors: Insufficient capital availability, Limited operating history, Economic downturns and volatility, Cloud service disruption, Labor/talent shortage/retention
- Current price 26.1% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.20$, 3.50$]
- 2026-12-31 to 2027-12-31 estimated range: [0.90$, 2.76$]
Financial Metrics affecting the BEAT estimates:
- Positive: with PPE of -4.3 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: 42.59 < Shareholder equity ratio, % of 44.55 <= 64.29
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term BEAT quotes
Long-term BEAT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $15.31MM | $19.89MM | $21.14MM |
| Operating Income | $-15.31MM | $-19.89MM | $-21.14MM |
| Non-Operating Income | $0.68MM | $0.44MM | $0.12MM |
| R&D Expense | $6.80MM | $11.05MM | $13.45MM |
| Income(Loss) | $-14.64MM | $-19.45MM | $-21.02MM |
| Net Income(Loss)* | $-14.64MM | $-19.45MM | $-21.02MM |
| Stockholders Equity | $15.94MM | $1.65MM | $2.60MM |
| Inventory | $0.00MM | $0.00MM | $0.10MM |
| Assets | $17.13MM | $3.28MM | $5.84MM |
| Operating Cash Flow | $-12.09MM | $-14.47MM | $-13.99MM |
| Capital expenditure | $0.26MM | $0.20MM | $0.60MM |
| Investing Cash Flow | $-0.26MM | $-0.20MM | $-0.60MM |
| Financing Cash Flow | $24.99MM | $0.87MM | $16.59MM |
| Earnings Per Share** | $-0.72 | $-0.73 | $-0.62 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.